DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
von Minckwitz G, Timms K, Untch M. et al.
Homologous repair deficiency (HRD) as measure to predict the effect of carboplatin on survival in the neoadjuvant phase II trial GeparSixto in triple-negative early breast cancer.
Cancer Res 2017;
77: P1-09-02
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.